NEW YORK, NY September 7, 2010 Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being covered are stenting in the femoral artery, polymer-free drug-eluting stents, valves and drug-eluting balloons used in angioplasty.
"The late breaking clinical trials and first report investigations scheduled for presentation at TCT 2010 will lead to important breakthroughs in patient care that are highly anticipated by the field of interventional cardiovascular medicine," said Gregg W. Stone, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Co-Director of the Medical Research and Education Division at the Cardiovascular Research Foundation. TCT is organized by the Cardiovascular Research Foundation and will be held September 21-25, 2010 in Washington, DC
The TCT 2010 final program is now available at: http://www.tctconference.com/pdf/TCT2010-final-program.pdf. The program is also now searchable online by presentations and speakers at: http://www.tctconference.com/program/program-agenda.html
THURSDAY, SEPTEMBER 23
FRIDAY, SEPTEMBER 24
SATURDAY, SEPTEMBER 25
|Contact: Judy Romero|
Cardiovascular Research Foundation